Class 2 medicine recall High risk 26 November 2020

Aventis Pharma Limited (t/a Sanofi), Largactil 50mg/2ml Solution for Injection

Yes – this has been recalled
The problem
Sanofi is recalling specific batches of Largactil 50mg/2ml Solution for Injection as a precautionary measure due to out of specification results obtained for the impurity chlorpromazine sulphoxide
What to do
Check the batch number on your pack against the list below. Do not stop taking a prescribed medicine without talking to your pharmacist, GP or prescriber first – they can check your supply and swap it if needed.
Source: Medicines and Healthcare products Regulatory Agency (MHRA) Official notice ↗

PL Number(s)

PL 04425/0582

MDR Number

MDR 140-11/20

Company Name

Aventis Pharma Limited (t/a Sanofi)

Product description

Largactil 50mg/2ml Solution for Injection

  • Batch Number: A90142
    • Expiry Date: 05/2022
    • Pack Size: 10x2ml ampoules
    • First Distributed: 08 April 2020
  • Batch Number: A90143
    • Expiry Date: 05/2022
    • Pack Size: 10x2ml ampoules
    • First Distributed: 10 June 2020

Active Pharmaceutical Ingredient: chlorpromazine hydrochloride

Brief description of the problem

Sanofi is recalling the above batches due to out of specification results obtained for the impurity chlorpromazine sulphoxide, which was suspected to be caused by increased oxidation as a result of higher oxygen content in the headspace of the ampoules. As a precautionary measure, the above batches are being recalled.

Advice for healthcare professionals

Stop supplying the above batches immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.

Further Information

For stock control enquiries please contact GB-CustomerServices@sanofi.com

Phone number: 0800 854 430

For more information or medical information at uk-medicalinformation@sanofi.com

Phone number: 0800 035 25 25

Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

Download document

Class 2 Medicines Recall: Aventis Pharma Limited (t/a Sanofi), Largactil 50mg/2ml Solution for Injection, EL (20)A/56

Updated 26 November 2020. This page summarises an official notice. Details can change – always follow the official notice.

Website built by: www.NocturnalMedia.co.uk